Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53 mutated B-cell prolymphocytic leukemia: a case report and review of literature
Keyword(s):
B Cell
◽
Not available.
2018 ◽
Vol 14
◽
pp. 69-72
◽
2015 ◽
Vol 4
(1)
◽
pp. 69